In Vitro Properties and Virulence of Contemporary Recombinant Influenza B Viruses Harboring Mutations of Cross-Resistance to Neuraminidase Inhibitors

Three neuraminidase inhibitors (NAIs: Oseltamivir, zanamivir and peramivir) are currently approved in many countries for the treatment of influenza A and B infections. The emergence of influenza B viruses (IBVs) containing mutations of cross-resistance to these NAIs constitutes a serious clinical th...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Clément Fage, Yacine Abed, Liva Checkmahomed, Marie-Christine Venable, Guy Boivin
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2018-12-01
Edice:	Viruses
Témata:	influenza B resistance fitness mouse model and neuraminidase mutation
On-line přístup:	http://www.mdpi.com/1999-4915/11/1/6
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!